Related references
Note: Only part of the references are listed.Virologic Correlates of Anti-CMV IgG Levels in HIV-1-Infected Men
Sara Gianella et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Cytomegalovirus Replication in Semen Is Associated with Higher Levels of Proviral HIV DNA and CD4+ T Cell Activation during Antiretroviral Treatment
Sara Gianella et al.
JOURNAL OF VIROLOGY (2014)
Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors
Edana Cassol et al.
BMC INFECTIOUS DISEASES (2013)
Shedding of HIV and Human Herpesviruses in the Semen of Effectively Treated HIV-1-Infected Men Who Have Sex With Men
Sara Gianella et al.
CLINICAL INFECTIOUS DISEASES (2013)
Increase in 2-Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial
Hiroyu Hatano et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Highly Precise Measurement of HIV DNA by Droplet Digital PCR
Matthew C. Strain et al.
PLOS ONE (2013)
Methamphetamine Use Among Women Attending Sexually Transmitted Disease Clinics in Los Angeles County
Shauna Stahlman et al.
SEXUALLY TRANSMITTED DISEASES (2013)
Methamphetamine Enhances Cryptococcus neoformans Pulmonary Infection and Dissemination to the Brain
Dhavan Patel et al.
MBIO (2013)
Associations between Virologic and Immunologic Dynamics in Blood and in the Male Genital Tract
Sara Gianella et al.
JOURNAL OF VIROLOGY (2012)
Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users
Nadia Fairbairn et al.
ADDICTIVE BEHAVIORS (2011)
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
Peter W. Hunt et al.
AIDS (2011)
Effect of methamphetamine on expression of HIV coreceptors and CC-chemokines by dendritic cells
Madhavan P. N. Nair et al.
LIFE SCIENCES (2011)
CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART
Marta Massanella et al.
AIDS (2010)
The Methamphetamine Problem in the United States
Rachel Gonzales et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 31 (2010)
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
Annemarie M. J. Wensing et al.
ANTIVIRAL RESEARCH (2010)
Methamphetamine Causes Mitrochondrial Oxidative Damage in Human T Lymphocytes Leading to Functional Impairment
Raghava Potula et al.
JOURNAL OF IMMUNOLOGY (2010)
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
Maria J. Buzon et al.
NATURE MEDICINE (2010)
The Origins of Sexually Transmitted HIV Among Men Who Have Sex with Men
David M. Butler et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Affective Correlates of Stimulant Use and Adherence to Anti-retroviral Therapy Among HIV-positive Methamphetamine Users
Adam W. Carrico et al.
AIDS AND BEHAVIOR (2010)
Short Communication: Methamphetamine Treatment Increases in Vitro and in Vivo HIV Replication
Sima Shelly Toussi et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Methamphetamine Enhances Histoplasmosis by Immunosuppression of the Host
Luis R. Martinez et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Methamphetamine Enhances HIV-1 Infectivity in Monocyte Derived Dendritic Cells
Madhavan P. N. Nair et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
Association of antiretroviral therapy with fibrinogen levels in HIV-infection
Erin Madden et al.
AIDS (2008)
Adding fuel to the fire: Methamphetamine enhances HIV infection
Raghava Potula et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Methamphetamine inhibits antigen processing, presentation, and phagocytosis
Zsolt Talloczy et al.
PLOS PATHOGENS (2008)
Experiences and sexual behaviors of HIV-infected MSM who acquired HIV in the context of crystal methamphetamine use
Matthew J. Mimiaga et al.
AIDS EDUCATION AND PREVENTION (2008)
Prevalence of nonmedical methamphetamine use in the United States
Todd M. Durell et al.
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2008)
The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007
Jane Carlisle Maxwell et al.
DRUG AND ALCOHOL REVIEW (2008)
Progressive CD4+ central-memory T cell decline results in CD4+ effector-memory insufficiency and overt disease in chronic SIV infection
Afam Okoye et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions
Steven Shoptaw et al.
ADDICTION (2007)
Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance
Grant Nash Colfax et al.
AIDS (2007)
Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment
Rachel Gonzales et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2006)
Methamphetamine administration produces immunomodulation in mice
SW In et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2005)
The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use
F Kapadia et al.
ADDICTION (2005)
Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons
JD Rippeth et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2004)
Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy
RJ Ellis et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
PW Hunt et al.
AIDS (2003)
The bioavailability of intranasal and smoked methamphetamine
DS Harris et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice
QL Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Share Paper
